drugset / Trial / NCT00688831
Single Ascending Dose Study (SAD) iv Formulation
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose is to study the safety of AZD1305, how AZD1305 is tolerated and how the medication is metabolised by the body (how it is taken up into the body, distributed around the body and disappears from the body
Timeline
- Start
- 2008-01
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD1305 | Small molecule | — | Intravenous |
Indications
No indication recorded.